204 related articles for article (PubMed ID: 9263349)
1. Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism--thesis, Rotterdam, 1981.
Michiels JJ
Semin Thromb Hemost; 1997; 23(4):335-8. PubMed ID: 9263349
[No Abstract] [Full Text] [Related]
2. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
[TBL] [Abstract][Full Text] [Related]
3. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.
van Genderen PJ; Michiels JJ
Presse Med; 1994 Jan; 23(2):73-7. PubMed ID: 8140075
[TBL] [Abstract][Full Text] [Related]
4. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
van Genderen PJ; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Michiels JJ
Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
[TBL] [Abstract][Full Text] [Related]
6. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
[TBL] [Abstract][Full Text] [Related]
7. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
[No Abstract] [Full Text] [Related]
8. Thrombocytosis and thrombocythemia.
Mitus AJ; Schafer AI
Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
[TBL] [Abstract][Full Text] [Related]
9. Erythromelalgia in a patient with thrombotic thrombocytopenic purpura.
Yosipovitch G; Krause I; Blickstein D
J Am Acad Dermatol; 1992 May; 26(5 Pt 2):825-7. PubMed ID: 1613144
[TBL] [Abstract][Full Text] [Related]
10. Classification of thrombocytosis based on platelet function tests: correlation with hemorrhagic and thrombotic complications.
Zucker S; Mielke CH
J Lab Clin Med; 1972 Sep; 80(3):385-94. PubMed ID: 5055386
[No Abstract] [Full Text] [Related]
11. [Physiopathology of thrombosis: prostaglandins].
Okuma M; Kanaji K; Ushikubi F; Sugiyama T; Sensaki S; Uchino H
Nihon Rinsho; 1986 May; 44(5):1051-7. PubMed ID: 3528564
[No Abstract] [Full Text] [Related]
12. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the platelet prostaglandin D2 receptor. Loss of prostaglandin D2 receptors in platelets of patients with myeloproliferative disorders.
Cooper B; Ahern D
J Clin Invest; 1979 Aug; 64(2):586-90. PubMed ID: 222813
[TBL] [Abstract][Full Text] [Related]
14. Essential thrombocythemia.
Schafer AI
Prog Hemost Thromb; 1991; 10():69-96. PubMed ID: 2008534
[No Abstract] [Full Text] [Related]
15. [Etiologic diagnosis of a digital necrosis: essential thrombocythemia. Review of the literature].
Rodat O
Sem Hop; 1979 Jan 18-25; 55(3-4):173-7. PubMed ID: 219524
[TBL] [Abstract][Full Text] [Related]
16. Platelets in the myeloproliferative syndrome.
Weinfeld A; Branehög I; Kutti J
Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
[No Abstract] [Full Text] [Related]
17. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
19. Acquired storage pool deficiency with increased platelet-associated IgG in a patient with compensated chronic idiopathic thrombocytopenic purpura.
Cortelazzo S; Casarotto C; D'Emilio A; Ricciardi O; Dini E
Haematologica; 1984; 69(1):81-4. PubMed ID: 6428998
[No Abstract] [Full Text] [Related]
20. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
